NEW: STA®-Liatest® D-Di Plus, Less interferences for even More Confidence
As part of Stago's continuous improvement commitment, STA® -Liatest® D-Di Plus* was developed as an evolution of the STA® -Liatest® D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of...
Read more
STA Compact Max®: Innovation born from Expertise
STA Compact Max® is the new generation of analyser developed by the Coagulation Company to meet labs' expectations.
Read more
New range of STA®-Routine QC quality control plasmas: The best range for routine laboratory tests
To fulfil regulatory requirements, laboratories must perform regular internal quality control (IQC) on at least two concentration levels (normal and abnormal) to check and confirm the performance of their testing systems.
Read more
STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control (CE marked)
Rivaroxaban is a new oral anticoagulant, direct factor Xa inhibitor, developed by Bayer HealthCare and sold under the trade name Xarelto®. It is approved in three indications in Europe: prevention of stroke and systemic embolism...
Read more
For every Heparin Induced Thrombocytopenia (HIT) suspicion. A rapid and specific exclusion of Heparin Induced Thrombocytopenia in 10 minutes. Diagnosing and treating Heparin Induced Thrombocytopenia (HIT) represent a challenge...
Read more